Abstract:Chiral benzoins are versatile precursors to various valuable synthons such as chiral hydrobenzoins and chiral vicinal amino alcohols. In principle, ketoreductase (KRED)-catalyzed asymmetric reduction of benzils could be one of the most straightforward, green, and stereoselective methods for the synthesis of chiral benzoins. Nevertheless, the practical application potential of this appealing approach has been hampered by the low substrate loadings (usually <10 g/L) and unsatisfactory catalytic efficiency reported to date. In the present work, through enzyme screening, wild-type (WT) ketoreductase SSCR was revealed to possess a decent specific activity of 69.8 U/mg against the unsubstituted benzil molecule 1a. Aided by structure-guided semirational protein engineering including alanine-scanning and site-saturation mutagenesis, SSCRQ245G, a variant of SSCR, was evolved with 5.0-fold improvement in specific activity (350.5 U/mg) and 7.0-fold enhancement in catalytic efficiency (1131 s(-1)mM(-1)), compared with the WT. By using SSCRQ245G as the reductase and employing glucose dehydrogenase (GDH) for the regeneration of nicotinamide adenine dinucleotide phosphate (NADPH), gratifyingly, as high as 100 g/L of 1a was completely reduced in a 5-gram-scale reaction, with the desired benzoin (S)-2a obtained in 96% isolated yield with 99% ee. Our developed biocatalytic synthesis also features a good space-time yield of 233 gL-1day(-1) and a decent E-factor of 44 (including water). Moreover, a three-step transformation of such biosynthesized benzoin (S)-2a into a synthetically useful chiral vicinal amino alcohol ligand 5 was realized in 64% overall yield. Finally, the synthetic potential of SSCRQ245G was further underscored by the smooth reduction of 16 other symmetrical and unsymmetrical benzils, delivering the corresponding chiral benzoins in 57-93% isolated yields with mostly good-to-excellent stereoselectivities (up to >99% ee). The current study not only provides efficient and sustainable access to chiral benzoins but also highlights the synthetic versatility of engineered ketoreductase-catalyzed stereoselective reduction of prochiral ketones.

Biocatalytic Stereoselective Synthesis of Chiral Precursors for Liposoluble β1 Receptor Blocker Nebivolol

Highly Efficient Synthesis of Chiral Alcohols with A Novel Nadh-Dependent Reductase from Streptomyces Coelicolor

Redesign of a Short-Chain Dehydrogenase/reductase for Asymmetric Synthesis of Ethyl (R)-2-hydroxy-4-phenylbutanoate Based on Per-Residue Free Energy Decomposition and Sequence Conservatism Analysis

Semi-rational Engineering of Carbonyl Reductase YueD for Efficient Biosynthesis of Halogenated Alcohols with in Situ Cofactor Regeneration

Chiral Syn-1,3-diol Derivatives via a One-Pot Diastereoselective Carboxylation/ Bromocyclization of Homoallylic Alcohols.

Enantioselective Desymmetrizing Hydroalkoxylation of 1,4-and 1,8-Diynes Enabled by Chiral Bronsted Acid Catalysis

A Three‐Step Chemoenzymatic Cascade Synthesis of Miconazole Analogues Based on the Asymmetric Synthesis of β‐Heteroaryl Amino Alcohols via Ketoreductases

Asymmetric Synthesis of Chiral Benzoins Enabled by Engineered Ketoreductase-Catalyzed Stereoselective Reduction of Benzils

Enantioselective Synthesis of Vicinal Diols by an Enzymatic Approach

Structure-Guided Tuning of a Hydroxynitrile Lyase to Accept Rigid Pharmaco Aldehydes

Iridium-catalyzed enantioselective synthesis of chiral -amino alcohols and intermediates of (<i>S</i>)-duloxetine, (<i>R</i>)-fluoxetine, and (<i>R</i>)-atomoxetine

Significantly Enhancing the Biocatalytic Synthesis of Chiral Alcohols by Semi-Rationally Engineering an Anti-Prelog Carbonyl Reductase from Acetobacter Sp. CCTCC M209061

Biocatalytic Asymmetric Reduction of a Sterically Hindered α-Bromo Ketone for the Synthesis of Key Intermediates of Olodaterol

Enantioselective Synthesis of Secondary <i></i>-Trifluoromethyl Alcoholsvia Catalytic Asymmetric Reductive Trifluoroalkylation and Diastereoselective Reduction

A Single Enzyme in Enantiocomplementary Synthesis of β-Nitroalcohols: Bidirectional Catalysis by Hydroxynitrile Lyase

Stereocomplementary bioreduction of β-ketonitrile without ethylated byproduct.

Enantioselective Synthesis of Secondary β-Trifluoromethyl Alcohols via Catalytic Asymmetric Reductive Trifluoroalkylation and Diastereoselective Reduction

Enantio‐ and Diastereoselective Synthesis of Chiral Syn ‐Aryl β‐Hydroxy α‐Amino Esters via Biocatalytic Dynamic Reductive Kinetic Resolution

Rational design of short-chain dehydrogenase/reductase for enantio-complementary synthesis of chiral 1,2-diols by successive hydroxymethylation and reduction of aldehydes

Engineering carbonyl reductase for one-pot chemobiocatalytic enantioselective synthesis of value-added N-containing chiral alcohol from N-acetyl-D-glucosamine

Ketoreductase-catalyzed dynamic reductive kinetic resolution of sterically hindered 2-aryl-1,5-benzothiazepin-3,4(2H,5H)-diones: asymmetric synthesis of a key diltiazem precursor and its analogues